Literature DB >> 12145145

A genetic switch in pancreatic beta-cells: implications for differentiation and haploinsufficiency.

Jorge Ferrer1.   

Abstract

Heterozygous mutations in the genes encoding transcriptional regulators hepatocyte nuclear factor (HNF)-1alpha and HNF-4alpha cause a form of diabetes known as maturity-onset diabetes of the young (MODY). Haploinsufficiency of HNF-1alpha or HNF-4alpha results in MODY because of defective function of pancreatic islet cells. In contrast, homozygous null mutations in mouse models lead to widespread and profound gene expression defects in multiple cell types. Thus, it is not surprising that HNF-1alpha function is now known to have distinct properties in pancreatic beta-cells. It controls a complex tissue-selective genetic network that is activated when pancreatic cells differentiate, and allows these cells to maintain critical specialized functions. The network contains an indispensable core component formed by a positive cross-regulatory feedback circuit between HNF-1alpha and HNF-4alpha. This type of circuit configuration can exhibit a switch-like behavior with two stable states. In the default active state, it can serve to perpetuate network activity in differentiated beta-cells. However, the loss of one HNF-1alpha or HNF-4alpha allele can increase the probability that the feedback circuit is permanently switched off, resulting in decreased expression of all four alleles selectively in beta-cells. Such a model can serve to rationalize key aspects of the pathogenic mechanism in MODY.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145145     DOI: 10.2337/diabetes.51.8.2355

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  27 in total

Review 1.  Transcriptional networks controlling pancreatic development and beta cell function.

Authors:  J M Servitja; J Ferrer
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

2.  Control of pancreas and liver gene expression by HNF transcription factors.

Authors:  Duncan T Odom; Nora Zizlsperger; D Benjamin Gordon; George W Bell; Nicola J Rinaldi; Heather L Murray; Tom L Volkert; Jörg Schreiber; P Alexander Rolfe; David K Gifford; Ernest Fraenkel; Graeme I Bell; Richard A Young
Journal:  Science       Date:  2004-02-27       Impact factor: 47.728

3.  Pleiotropic effects of HNF1A rs1183910 in a population-based study of 60,283 individuals.

Authors:  Kristine H Allin; Børge G Nordestgaard
Journal:  Diabetologia       Date:  2014-01-19       Impact factor: 10.122

4.  Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection.

Authors:  E R Pearson; S Pruhova; C J Tack; A Johansen; H A J Castleden; P J Lumb; A S Wierzbicki; P M Clark; J Lebl; O Pedersen; S Ellard; T Hansen; A T Hattersley
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

5.  Differential effects of HNF-1α mutations associated with familial young-onset diabetes on target gene regulation.

Authors:  Maria Galán; Carmen-Maria García-Herrero; Sharona Azriel; Manuel Gargallo; Maria Durán; Juan-Jose Gorgojo; Victor-Manuel Andía; Maria-Angeles Navas
Journal:  Mol Med       Date:  2010-12-15       Impact factor: 6.354

6.  The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion.

Authors:  Rana K Gupta; Marko Z Vatamaniuk; Catherine S Lee; Reed C Flaschen; James T Fulmer; Franz M Matschinsky; Stephen A Duncan; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2005-03-03       Impact factor: 14.808

7.  Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A.

Authors:  Jason W Hoskins; Jinping Jia; Marta Flandez; Hemang Parikh; Wenming Xiao; Irene Collins; Mickey A Emmanuel; Abdisamad Ibrahim; John Powell; Lizhi Zhang; Nuria Malats; William R Bamlet; Gloria M Petersen; Francisco X Real; Laufey T Amundadottir
Journal:  Carcinogenesis       Date:  2014-09-18       Impact factor: 4.944

8.  Epistasis of transcriptomes reveals synergism between transcriptional activators Hnf1alpha and Hnf4alpha.

Authors:  Sylvia F Boj; Dimitri Petrov; Jorge Ferrer
Journal:  PLoS Genet       Date:  2010-05-27       Impact factor: 5.917

9.  Hepatocyte nuclear factor 4alpha enhances the hepatocyte nuclear factor 1alpha-mediated activation of transcription.

Authors:  J Eeckhoute; P Formstecher; B Laine
Journal:  Nucleic Acids Res       Date:  2004-05-11       Impact factor: 16.971

10.  The G115S mutation associated with maturity-onset diabetes of the young impairs hepatocyte nuclear factor 4alpha activities and introduces a PKA phosphorylation site in its DNA-binding domain.

Authors:  Bénédicte Oxombre; Mostafa Kouach; Ericka Moerman; Pierre Formstecher; Bernard Laine
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.